Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

LillyDirect Foundayo vs MyStart Health

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

8.5

LillyDirect Foundayo

Best for patients with commercial insurance who want the cheapest legal brand-name GLP-1
★★★★4.3

Starting at $25/mo

Manufacturer DirectFoundayoBrand NameLilly Savings Card
Visit LillyDirect Foundayo
7.7

MyStart Health

Best for fastest compounded GLP-1 onboarding with a price lock
★★★3.9

Starting at $299/mo

CompoundedSemaglutideTirzepatidePrice Lock Guarantee
Visit MyStart Health

Side-by-Side Comparison

FeatureLillyDirect FoundayoMyStart Health
Overall Score8.5/107.7/10
Starting Price$25/mo$299/mo
Editorial Rating4.3 ★ /53.9 ★ /5
Features5 features6 features
States Available510
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

LillyDirect Foundayo

Pros

  • Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
  • Direct from manufacturer — no compounding, no third-party reseller
  • Daily oral pill, no injections, no refrigeration
  • Available in all 50 states

Cons

  • Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
  • Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
  • $25 savings card requires commercial insurance — Medicare and Medicaid not eligible
  • Strict empty-stomach 30-minute window may be hard for some patients to follow

MyStart Health

Pros

  • Price Lock Guarantee — base monthly rate ($299) doesn't increase even when your prescribed dose escalates
  • Fast onboarding: quoted 5-minute intake, 24-hour prescription turnaround, 2–4 day shipping
  • 24/7 access to the care team with unlimited clinician messaging included
  • LegitScript certified
  • Transparent Section 503A compounding disclosure on every landing page

Cons

  • Not BBB accredited — BBB rating of C+ with 10 complaints filed against the business (BBB file opened April 24, 2025), most involving shipping delays and customer service access issues in early 2026
  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
  • Oral tirzepatide referenced in marketing but FAQ clarifies injectable is 'currently more common' — no FDA-approved oral tirzepatide exists, and the November 2025 Chimicles class action against OpenLoop/Triad Rx over unapproved oral tirzepatide products is a cautionary data point for the category
  • Very recent company (incorporated May 21, 2024 per BBB) — limited operational track record
  • Pharmacy partners not publicly named — no independent way to verify 503A compliance
  • Clinical efficacy claims are based on a homepage survey of only 16 self-reporting customers

Our Verdict

Winner: LillyDirect FoundayoScore: 8.5/10

LillyDirect Foundayo edges out MyStart Health with a higher overall score of 8.5/10 and is particularly strong for patients with commercial insurance who want the cheapest legal brand-name GLP-1. MyStart Health remains a solid alternative, especially if you're looking for fastest compounded GLP-1 onboarding with a price lock.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.